Loading...
Effectiveness of a novel, fixed dose combination of netupitant and palonosetron in prevention of chemotherapy induced nausea and vomiting: A real-life study from India
BACKGROUND: A new, oral fixed dose combination of highly selective neurokinin-1 receptor antagonist, netupitant with 5HT3 receptor antagonist, netupitant and palonosetron (NEPA) was approved in India for prevention of chemotherapy induced nausea and vomiting (CINV). AIM: To assess effectiveness of N...
Na minha lista:
| Udgivet i: | World J Clin Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Inc
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7443837/ https://ncbi.nlm.nih.gov/pubmed/32879847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v11.i8.606 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|